Related Experiment Video
Updated: Jun 15, 2025

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
Subtle Cognitive Impairments and Psychological Complaints in Patients With Prolactinoma Despite Biochemical Control
Victoria R van Trigt1, Cornelie D Andela1,2, Leontine E H Bakker1
1Department of Medicine, Division of Endocrinology, and Center for Endocrine Tumors Leiden, Leiden University Medical Center, Leiden, 2333 ZA, the Netherlands.
Purpose:
To assess cognitive functioning and psychological complaints in patients with biochemically controlled prolactinoma.
Methods:
Cross-sectional study comparing otherwise healthy patients treated for prolactinoma to age-, gender-, and education level-matched controls. The cognitive assessment included 8 tests assessing memory, verbal fluency, processing speed, selective attention, and executive functioning. Additionally, patients completed 7 validated questionnaires on psychological complaints. Generalized estimating equations were performed. P values <.050 were considered significant.
Results:
Sixty patients (controlled on dopamine agonists, n = 30; in surgical remission, n = 30), among whom 41 (68.3%) females, aged 42.3 ± 11.7 years, were compared to 60 matched controls. Patients scored significantly lower on assessments for verbal memory (fewer words on Verbal Learning Test of Rey: β = -1.8; 95% CI, -2.7 to -1.0), selective attention (fewer correct digits on Digit Deletion Test [β = -8.8; 95% CI, -16.2 to -0.2], longer time on Trial Making Test A [β = 5.2; 95% CI, 3.2 to 7.2]), and processing speed (fewer correct substitutions on Digit-Symbol Substitution Test: β = -4.2; 95% CI, -8.2 to -0.2). Furthermore, patients reported higher degrees of apathy (Apathy Scale: β = 2.4; 95% CI, 0.6 to 4.1), irritability (Irritability Scale: β = 2.2; 95% CI, 0.3 to 4.1), fatigue (Fatigue Severity Scale: β = 6.7; 95% CI, 2.7 to 10.8), and anxiety and depressive symptoms (Hospital Anxiety and Depression Scale, anxiety: β = 1.1; 95% CI, 0.1 to 2.1; depression: β = 1.7; 95% CI, 0.8 to 2.7). Tests assessing executive functioning and task switching were comparable in patients and matched controls.
Conclusion:
Compared to matched controls, patients with biochemically controlled prolactinoma showed subtle cognitive impairments (ie, memory, attention, and processing speed) and reported more psychological complaints. Physicians should be aware of these impairments and address them adequately.
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Negative and Cognitive Symptoms of Schizophrenia
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Parkinson's Disease: Overview
Neural Regulation
Major Hormones and Their Functions
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

